0.27
-0.0037(-1.36%)
Currency In USD
| Previous Close | 0.27 |
| Open | 0.27 |
| Day High | 0.28 |
| Day Low | 0.26 |
| 52-Week High | 0.93 |
| 52-Week Low | 0.22 |
| Volume | 1.13M |
| Average Volume | 2M |
| Market Cap | 11.13M |
| PE | -0.13 |
| EPS | -2.07 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 0.38 |
| Change | -0 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $202.95 as of November 13, 2025 at a share price of $0.268. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $71.63 as of November 13, 2025 at a share price of $0.268.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
GlobeNewswire Inc.
Oct 29, 2025 12:30 PM GMT
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives Expected to Begin in Early 2026 UNI
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
GlobeNewswire Inc.
Oct 28, 2025 12:00 PM GMT
UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it has engaged RedChip Companies (“RedChip”)
ProPhase Labs to Present at the 2025 ThinkEquity Conference
GlobeNewswire Inc.
Oct 24, 2025 12:00 PM GMT
UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it will be participating in the ThinkEquity